Prevention of transfusion-transmitted cytomegalovirus infection.
about
Bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for haematological malignanciesData-driven blood banking practices for neonatal RBC transfusions.Alternatives to standard blood transfusion: availability and promise.Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.The modern management of severe aplastic anaemia.Leucocyte depletion of the blood supply - how will patients benefit?Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement.Universal WBC reduction: the case for and against.Paediatric transfusion.Human Cytomegalovirus (HCMV) - Revised.Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.Viruses.Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodiesTransfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.Transfusion strategies in patients undergoing stem-cell transplantation.Supportive care in severe and very severe aplastic anemia.Colonic perforation in a patient with systemic lupus erythematosus accompanied by cytomegalovirus infection: A case report.Molecular epidemiology of human Herpesviruses types 1-6 and 8 among Greek blood donors.High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV.The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.Quality of packed red blood cells and platelet concentrates collected by multicomponent collection using the MCS plus device.Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression.Comparison of the two fully automated anti-HCMV IgG assays: Abbott Architect CMV IgG assay and Biotest anti-HCMV recombinant IgG ELISA.The convergent epidemiology of tuberculosis and human cytomegalovirus infection.Quality control of leucoreduced cellular blood components in France
P2860
Q24197741-5D5653F7-982C-4937-AA71-58F51B6DDADCQ30622126-CE1012EB-5833-4DF0-8177-5F46E97D0726Q33785932-27C4BD9E-94D8-4F3F-8889-B2500951C678Q33929670-D9EB8C20-DF63-4332-B165-FED43460A46DQ33994359-CF839B5B-04BE-41E9-A214-BBEEDC75D911Q34022474-7F238895-7701-4F25-A3CD-89271B45B4EAQ34228258-B845EB35-B370-4FE4-AABF-B46B54126BB3Q34247853-691E35F2-5C7B-45EA-AB12-2B35597E5743Q34345113-D3B35FD4-A667-4205-96B5-C703CFFF209EQ34625453-781A01EF-A1F0-41BD-9679-B786CB4BC86BQ35732096-F5C9B172-5982-4187-BEE3-BEDADDF132E7Q35807463-1D59F770-C1D1-4F55-94FA-5A6BA37923E6Q37196366-B7C22125-EB77-4D31-A3EC-F0E84D6F0782Q37323823-868C18AE-E3CA-4445-AF2B-A3AB8DA99491Q37865548-318077D0-2E5C-4D0D-AB48-1C27D37CF4F4Q38064773-C4AB4D49-7931-4F3C-B6A5-3725DDCEB46DQ40109239-F0691495-9BB8-4972-B7AB-4149F6D39731Q40977006-0C54212F-4B93-4A1F-9F4E-89590B9E5AB4Q43586526-59E72447-E8D6-460F-B9FB-9FDB40C32CECQ44117312-D6A33EE1-8C92-4B2E-85CC-BF0C6E75DB33Q44419679-96923B62-7AC3-4998-8538-4D251CF9E004Q48305722-D9BDC45D-BFBA-45DE-8AD5-D5427B9968AAQ51074281-6567BA5B-5547-4DB6-BE7D-44CF8E61269BQ54202530-B1A1C135-EB22-46C9-90AC-A63C14829493Q56833964-02C4BF5D-752E-4C0B-82AD-823DD8E74DA8
P2860
Prevention of transfusion-transmitted cytomegalovirus infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prevention of transfusion-transmitted cytomegalovirus infection.
@ast
Prevention of transfusion-transmitted cytomegalovirus infection.
@en
type
label
Prevention of transfusion-transmitted cytomegalovirus infection.
@ast
Prevention of transfusion-transmitted cytomegalovirus infection.
@en
prefLabel
Prevention of transfusion-transmitted cytomegalovirus infection.
@ast
Prevention of transfusion-transmitted cytomegalovirus infection.
@en
P2093
P2860
P1433
P1476
Prevention of transfusion-transmitted cytomegalovirus infection.
@en
P2093
Barbara JA
Pamphilon DH
Williamson LM
P2860
P304
P356
10.1046/J.1365-3148.1999.00193.X
P577
1999-06-01T00:00:00Z